{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:26Z","timestamp":1790803106330,"version":"4.1.0"},"reference-count":91,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"BioNet Europe"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2473328","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:54:21Z","timestamp":1741172061000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["How to improve pertussis vaccination in pregnancy: a European expert review"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-5668","authenticated-orcid":false,"given":"Adam","family":"Finn","sequence":"first","affiliation":[{"name":"University of Bristol","place":["Bristol, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-4028","authenticated-orcid":false,"given":"Nicole","family":"Guiso","sequence":"additional","affiliation":[{"name":"Independent Consultant","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1914-013X","authenticated-orcid":false,"given":"Carl Heinz","family":"Wirsing von K\u00f6nig","sequence":"additional","affiliation":[{"name":"Independent Consultant","place":["Krefeld, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-581X","authenticated-orcid":false,"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario de Santiago (SERGAS) and University of Santiago de Compostela (USC)","place":["Santiago de Compostela, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS)","place":["Santiago de Compostela, Spain"]},{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-8896","authenticated-orcid":false,"given":"Arto A.","family":"Palmu","sequence":"additional","affiliation":[{"name":"FVR - Finnish Vaccine Research","place":["Tampere, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-0804","authenticated-orcid":false,"given":"Pierre","family":"Bakhache","sequence":"additional","affiliation":[{"name":"INFOVAC, French Association of Ambulatory Pediatrics","place":["Toulon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-3547","authenticated-orcid":false,"given":"Helena C.","family":"Maltezou","sequence":"additional","affiliation":[{"name":"National Public Health Organization","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-1249","authenticated-orcid":false,"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[{"name":"Vaccinopolis, University of Antwerp","place":["Wilrijk, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1791092"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15311"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60686-3"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw559"},{"key":"e_1_3_6_7_1","unstructured":"UK Health Security Agency (UKHSA). Confirmed cases of pertussis in England by month. Available from: https:\/\/www.gov.uk\/government\/publications\/pertussis-epidemiology-in-england-2024\/confirmed-cases-of-pertussis-in-england-by-month"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01344"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3836"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197970"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.6364"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.021"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.944167"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160193"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200850"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3326"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029553"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.1664"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac432"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1192119"},{"key":"e_1_3_6_21_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Increase of pertussis cases in the EU\/EEA. Stockholm. 2024 [cited 2024 May 30]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Increase%20in%20pertussis%20cases%20in%20the%20EU-EEA%20-%20May%202024%20FINAL.pdf"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107148"},{"key":"e_1_3_6_23_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Vaccine schedules in all countries in the EU\/EEA. [cited 2024 Jul 10]. Available from: https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.23.2400301"},{"key":"e_1_3_6_25_1","unstructured":"Novonite.com. Bulgaria offers free whooping cough vaccines for pregnant women amid rising cases. Sofia; 2024 Apr 26 [cited 2024 Sep 2]. Available from: https:\/\/www.novinite.com\/articles\/225845\/Bulgaria+Offers+Free+Whooping+Cough+Vaccines+for+Pregnant+Women+Amid+Rising+Cases#:~:text=Additionally %20all%20pregnant%20women%20within%20the"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.14218\/OnA.2024.00016"},{"key":"e_1_3_6_27_1","unstructured":"THL recommends whooping cough vaccine in pregnancy \u2013 the reason is an increase in cases which may be dangerous for babies [Internet]. 2024 Aug 23 [cited 2024 Sep 2]. Available from: https:\/\/thl.fi\/en\/-\/thl-recommends-whooping-cough-vaccine-in-pregnancy-the-reason-is-an-increase-in-cases-which-may-be-dangerous-for-babies"},{"key":"e_1_3_6_28_1","article-title":"Prenatal pertussis vaccination coverage in England from January to March 2024, and annual coverage for 2023 to 2024","author":"UK Health Security Agency (UKHSA)","unstructured":"UK Health Security Agency (UKHSA). Prenatal pertussis vaccination coverage in England from January to March 2024, and annual coverage for 2023 to 2024. Updated. Jul 2024[cited 2024 Aug 28].Available from11.doi:https:\/\/www.gov.uk\/government\/publications\/pertussis-immunisation-in-pregnancy-vaccine-coverage-estimates-in-england-october-2013-to-march-2014\/prenatal-pertussis-vaccination-coverage-in-england-from-january-to-march-2024-and-annual-coverage-for-2023-to-2024","journal-title":"Updated"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q1289"},{"issue":"41","key":"e_1_3_6_30_1","first-page":"1424","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (tdap) in pregnant women and persons who have or anticipate having closecontact with an infant aged <12 months","volume":"60","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2011","unstructured":"Advisory Committee on Immunization Practices (ACIP). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (tdap) in pregnant women and persons who have or anticipate having closecontact with an infant aged <12 months. Morbidity and Mortal Wkly Report (MMWR). 2011;60(41):1424\u20131426.","journal-title":"Morbidity and Mortal Wkly Report (MMWR)"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10121990"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.104"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.001"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.105"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100087"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.5689"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062664"},{"key":"e_1_3_6_38_1","unstructured":"UK Health Security Agency (UKHSA). Complete routine immunisation schedule from 1. 2024 Jul [cited 2024 Aug 20]. https:\/\/www.gov.uk\/government\/publications\/the-complete-routine-immunisation-schedule\/the-complete-routine-immunisation-schedule-from-february-2022#complete-routine-immunisation-schedule-from-1-september-2023"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.074"},{"key":"e_1_3_6_40_1","unstructured":"European Medicines Agency (EMA). Abrysvo respiratory syncytial virus vaccine 2024 Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abrysvo"},{"key":"e_1_3_6_41_1","unstructured":"National RSV vaccination programme announced [Internet]. 2024 Jul 2024 [cited Aug 20]. https:\/\/www.gov.uk\/government\/news\/national-rsv-vaccination-programme-announced"},{"key":"e_1_3_6_42_1","unstructured":"Vaccination maternelle contre le VRS: une nouvelle possibilit\u00e9 pour prot\u00e9ger le nouveau-n\u00e9 [Internet]. 2024;13 Available from: https:\/\/www.has-sante.fr\/jcms\/p_3522378\/fr\/vaccination-maternelle-contre-le-vrs-une-nouvelle-possibilite-pour-proteger-le-nouveau-ne"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S203454"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.087"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab505"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad560"},{"key":"e_1_3_6_47_1","volume-title":"Presented at 6th Internal Neonatal & Maternal Immunization Symposium","author":"Chawana R","year":"2024","unstructured":"Chawana R, Jongihlati B, Snaggs H, et al. A phase 2b trial to evaluate the safety, tolerability, and immunogenicity of a multivalent GBS6 vaccine when administered concomitantly with Tdap (abstract). In: Presented at 6th Internal Neonatal & Maternal Immunization Symposium; INMIS); San Jose, Costa Rica; 2024."},{"key":"e_1_3_6_48_1","unstructured":"UK Health Security Agency (UKHSA). Guidance. RSV vaccination of pregnant women for infant protection: information for healthcare practitioners. Published. 2024 Jul 12 [cited 2024 Sep 23]. Available from: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-rsv-programme-information-for-healthcare-professionals\/rsv-vaccination-of-pregnant-women-for-infant-protection-information-for-healthcare-practitioners"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001767"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30426-2"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q1669"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001601"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.06.010"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1749597"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.001"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689394"},{"issue":"6","key":"e_1_3_6_57_1","first-page":"53","article-title":"Tetanus vaccines: WHO position paper \u2013 February 2017","volume":"92","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO). Tetanus vaccines: WHO position paper \u2013 February 2017. Wkly Epidemiol Rec. 2017;92(6):53\u201376.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.01.035"},{"key":"e_1_3_6_59_1","unstructured":"UK Health Security Agency (UKHSA). Prenatal pertussis vaccine change from July 2024 letter. Published 28. May 2024. [cited 2024 Aug 30]. Available from: https:\/\/www.gov.uk\/government\/publications\/prenatal-pertussis-vaccine-change-from-july-2024-letter\/prenatal-pertussis-vaccine-change-from-july-2024-letter"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.02.065"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0497-374"},{"key":"e_1_3_6_62_1","unstructured":"National Health Security Office (NHSO). Thailand. Acellular pertussis vaccines offered to pregnant women. Thailand. 2023 Jul 05 [cited 2024 Sep 2]. Available from: https:\/\/eng.nhso.go.th\/view\/1\/home\/News\/536\/EN-US"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit531"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.944902"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.147"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11100557"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13090623"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.36.30334"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay9258"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00561-10"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00230-X"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.09.003"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1105136"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1097(92)90060-2"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1999.0189"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(95)70301-2"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602083340601"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.5.e81"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.96.3.548"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83181-6"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01520"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01153-3"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1385686"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.10.076"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30612-6"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02644-7"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy594"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.001"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100976"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.11.042"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107047"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.070"},{"key":"e_1_3_6_93_1","first-page":"e83449","volume-title":"A phase I clinical study of a live attenuated bordetella pertussis vaccine\u2013BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","author":"Thorstensson R","year":"2014","unstructured":"Thorstensson R, Trollfors B, Al-Tawil N, et al. A phase I clinical study of a live attenuated bordetella pertussis vaccine\u2013BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLOS ONE. 2014;9(1):e83449."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2473328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:42:21Z","timestamp":1765521741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2473328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2473328"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2473328","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}